We are live on
!
Find out more
PC
Pecaut & Co Portfolio holdings
AUM
$328M
1-Year Est. Return
21.14%
This Fund
S&P 500
This Quarter
Est. Return
-0.22%
1 Year Est. Return
+21.14%
3 Year Est. Return
+67.58%
5 Year Est. Return
+93.35%
10 Year Est. Return
+426.07%
AUM
$168M
AUM Growth
+$14.1M
(+9.2%)
Cap. Flow
+$15.4M
Cap. Flow
% of AUM
9.19%
Top 10 Holdings %
Top 10 Hldgs %
60.51%
Holding
84
New
2
Increased
19
Reduced
31
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$11.1M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$5.53M |
| 3 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$1.38M |
| 4 |
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
|
+$1.35M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$1.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$4.13M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$1.69M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$811K |
| 4 |
Apple
AAPL
|
+$672K |
| 5 |
Restaurant Brands International
QSR
|
+$666K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.27% |
| 2 | Financials | 25.52% |
| 3 | Technology | 12.88% |
| 4 | Communication Services | 12.53% |
| 5 | Consumer Staples | 5.33% |
Similar funds
SC
NA
KWM
VPF
KA
DIP
EWA
EAM
Pecaut & Co's Q3 2021 Portfolio in Review
As of Q3 2021, Pecaut & Co held 84 positions worth $168M, up 9.2% from $154M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Pecaut & Co deployed $15.4M of net new capital in Q3 2021, opening 2 new positions and adding to 19 existing holdings. Its largest new stake was First Trust NYSE Arca Biotechnology Index Fund: 2,663 shares worth $442K.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 13% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $1.69M trimmed.
- Pecaut & Co's largest Q3 2021 buy was First Trust NYSE Arca Biotechnology Index Fund: 2,663 shares worth $442K.
- Pecaut & Co added most to State Street SPDR Portfolio Short Term Corporate Bond ETF in Q3 2021, an estimated $11.1M increase.
- Pecaut & Co's biggest Q3 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $1.69M.
- Pecaut & Co fully exited Mastercard in Q3 2021, selling an estimated $4.13M.
- Pecaut & Co's ten largest holdings make up 61% of its $168M portfolio in Q3 2021.
- Pecaut & Co opened 2 new positions and closed 4 in Q3 2021.
- Pecaut & Co's portfolio value rose 9.2% quarter-over-quarter to $168M.
Based on Pecaut & Co's 13F filing for Q3 2021, filed 5 Nov 2021.